Literature DB >> 32030835

Lmo4-resistin signaling contributes to adipose tissue-liver crosstalk upon weight cycling.

Yu Sun1, Mengyuan Geng1, Yangmian Yuan1, Peilian Guo1, Yuchen Chen2, Dong Yang2, Robert B Petersen3, Kun Huang2, Ling Zheng1,4.   

Abstract

Repeated cycles of weight loss and regain, known as weight cycling, is often seen when people try to lose weight. The exact pathophysiological effects and the underlying mechanisms of weight cycling remain largely unclear. Here, we report that weight cycling induced by alternating feeding mice with a low-fat diet or a high-fat diet in a 1-week switch protocol caused further increased epididymal white adipose tissue (eWAT) weight, preadipocyte proliferation, hepatic inflammation, fasting blood glucose level, and glucose intolerance, compared with the continuously HF-fed mice. Combining the secretory protein database with RNA-sequencing and quantitative PCR (qPCR) results in eWAT, the mRNA levels of several adipokines, including Retn (encoding resistin), were found altered by weight cycling. A transcriptional co-factor Lmo4 was found regulated by weight cycling; Lmo4 enhanced preadipocyte proliferation, in vitro adipogenesis, transcription of Retn, and resistin secretion in 3T3-L1 cells. Primary mouse hepatocytes administrated with recombinant mouse resistin (rm-resistin), or exposed to media from Lmo4-overexpressed 3T3-L1 cells, showed increased inflammatory responses and gluconeogenesis. Furthermore, rm-resistin-injected normal chow-fed mice showed upregulated blood glucose level by increasing gluconeogenesis, and upregulated the hepatic inflammatory responses. Together, our results suggest a regulatory role of Lmo4-resistin signaling in weight cycling, indicating a crosstalk between the adipose tissue and liver.
© 2020 Federation of American Societies for Experimental Biology.

Entities:  

Keywords:  Lmo4; adipose tissue-liver crosstalk; diet-induced weight cycling; hepatic inflammation; resistin

Year:  2020        PMID: 32030835     DOI: 10.1096/fj.201902708R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  3 in total

1.  Renal UTX-PHGDH-serine axis regulates metabolic disorders in the kidney and liver.

Authors:  Hong Chen; Chong Liu; Qian Wang; Mingrui Xiong; Xia Zeng; Dong Yang; Yunhao Xie; Hua Su; Yu Zhang; Yixue Huang; Yuchen Chen; Junqiu Yue; Chengyu Liu; Shun Wang; Kun Huang; Ling Zheng
Journal:  Nat Commun       Date:  2022-07-04       Impact factor: 17.694

2.  An RNAi Screening of Clinically Relevant Transcription Factors Regulating Human Adipogenesis and Adipocyte Metabolism.

Authors:  Christel Björk; Narmadha Subramanian; Jianping Liu; Juan Ramon Acosta; Beatriz Tavira; Anders B Eriksson; Peter Arner; Jurga Laurencikiene
Journal:  Endocrinology       Date:  2021-07-01       Impact factor: 4.736

3.  Histone H1.2 promotes hepatocarcinogenesis by regulating signal transducer and activator of transcription 3 signaling.

Authors:  Qing Wang; Yuchen Chen; Yunhao Xie; Dong Yang; Yuyan Sun; Yangmian Yuan; Hong Chen; Yu Zhang; Kun Huang; Ling Zheng
Journal:  Cancer Sci       Date:  2022-03-30       Impact factor: 6.518

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.